MedChemExpress Ralimetinib dimesylate (LY2228820 dimesylate) is a selective, ATP-competitive inhibitor of p38 MAPK α/β with IC50s of 5.3 and 3.2 nM, respectively. Ralimetinib (LY2228820) selectively inhibits phosphorylation of MK2 (Thr334), with no effect on phosphorylation of p38a MAPK, JNK, ERK1/2, c-Jun, ATF2, or c-Myc.

Precio y disponibilidad
Especificaciones

Sinónimo	LY2228820 dimesylate
Información de solubilidad	DMSO : 61 mg/mL (99.55 mM; Need ultrasonic and warming)
Forma física	Solid
Almacenamiento recomendado	4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture)
Color	Yellow
SMILES	FC1=CC=C(C=C1)C2=C(NC(C(C)(C)C)=N2)C3=NC4=C(C=C3)N=C(N)N4CC(C)(C)C.OS(C)(=O)=O.OS(C)(=O)=O
Notas de grado de pureza	Research
Duración de almacenamiento	4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture)
Formula Weight (peso de la fórmula)	612.74
Fórmula molecular	C₂₆H₃₇FN₆O₆S₂
CAS	862507-23-1
Nombre del producto químico o material	Ralimetinib dimesylate
Porcentaje de pureza	96.97%
Peso molecular (g/mol)	612.74
Grado	Research
Para utilizar con (aplicación)	Cancer-Kinase/protease

CAS RN 862507-23-1

Resultados de la búsqueda filtrada

Limitar resultados